Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jun 6, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6041-25
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)
Initial Posting
Jun 6, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.